Cardiac resynchronization therapy in the real world: need to focus on implant rates, patient selection, co-morbidities, type of devices, and complications
Author:
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/article-pdf/38/27/2129/18541461/ehx137.pdf
Reference18 articles.
1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC;Eur Heart J,2016
2. Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes;Curr Heart Fail Rep,2014
3. Cost-effectiveness of cardiac resynchronisation therapy;Heart,2012
4. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA);Europace,2013
5. Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association;Eur Heart J,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II;European Heart Journal - Quality of Care and Clinical Outcomes;2023-04-19
2. ObsErvatioNal prospective multicenter stuDy tO characterize the cLinical ANd DiagnoStiC feAtures of endocarditis in the contemPorary Era (ENDO-LANDSCAPE study): rationale and design;Journal of Cardiovascular Medicine;2023-04-06
3. A Novel Approach for Repetitive Dislocation of Transvenous Left Ventricular Leads During Cardiac Resynchronization Therapy Implantation by the Loop Technique;Frontiers in Cardiovascular Medicine;2022-06-21
4. Mehran risk score model for predicting contrast-induced nephropathy after cardiac resynchronization therapy in patients with heart failure;Gulhane Medical Journal;2022-03-07
5. Heart failure in the last year: progress and perspective;ESC Heart Failure;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3